[联合检测血清NLR,PSA和MMP26在区分前列腺癌和良性前列腺增生]
Yi-Jin Wang1, Qiang Li2, Guang-Bo Fu3
1Department of Urology, Affiliated Huai 'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu 223002, China.
Zhonghua nan ke xue = National journal of andrology
|August 11, 2025
概括
血清中性粒细胞与淋巴细胞比率 (NLR),前列腺特异抗原 (PSA) 和MMP26的联合检测有效地区分前列腺癌 (PCa) 与良性前列腺增生 (BPH). 这种综合方法显示出作为PCa早期查工具的前景.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 在瘤学瘤学.
- 生物化学 生物化学
更多相关视频
08:40Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
Published on: April 8, 2016
12.9K
08:05Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
Published on: June 10, 2025
667